1. Current Prospects for the Fluoroquinolones as First-Line Tuberculosis Therapy
Howard Takiff and Elba Guerrero
Phillip J. Bergen, Brian T. Tsuji, Jurgen B. Bulitta, Alan Forrest, Jovan Jacob, Hanna E. Sidjabat, David L. Paterson, Roger L. Nation and Jian Li
3. In Vitro Activities of Daptomycin-, Vancomycin-, and Teicoplanin-Loaded Polymethylmethacrylate against Methicillin-Susceptible, Methicillin-Resistant, and Vancomycin-Intermediate Strains of Staphylococcus aureus
Yuhan Chang, Wen-Chien Chen, Pang-Hsin Hsieh, Dave W. Chen, Mel S. Lee, Hsin-Nung Shih, and Steve W. N. Ueng
P. Campoli, Q. Al Abdallah, R. Robitaille, N. V. Solis, J. A. Fielhaber, A. S. Kristof,M. Laverdiere, S. G. Filler, and D. C. Sheppard
No comments:
Post a Comment